Forte Biosciences (FBRX) EPS (Diluted) (2021 - 2026)
Forte Biosciences (FBRX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.15 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -368,323.02 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.02 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.75 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.33 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | -26.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.29 |
| Dec 31, 2025 | -29.24 |
| Sep 30, 2025 | -42.52 |
| Jun 30, 2025 | -29.23 |
| Mar 31, 2025 | -18.60 |
| Dec 31, 2024 | -8.83 |
| Sep 30, 2024 | -10.28 |
| Jun 30, 2024 | -15.26 |
| Mar 31, 2024 | -9.30 |
| Dec 31, 2023 | -7.62 |
| Sep 30, 2023 | -12.14 |
| Jun 30, 2023 | -10.83 |
| Mar 31, 2023 | -8.24 |
| Dec 31, 2022 | -7.20 |
| Sep 30, 2022 | -4.65 |
| Jun 30, 2022 | -5.48 |
| Mar 31, 2022 | -4.77 |
| Dec 31, 2021 | -23.06 |
| Sep 30, 2021 | -15.33 |
| Jun 30, 2021 | -53.15 |